Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Design of future rabies biologics and antiviral drugs.

Smith TG, Wu X, Franka R, Rupprecht CE.

Adv Virus Res. 2011;79:345-63. doi: 10.1016/B978-0-12-387040-7.00016-0. Review.

PMID:
21601054
[PubMed - indexed for MEDLINE]
2.

Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.

Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett SM, Levis R, Meltzer MI, Schaffner W, Cieslak PR; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Mar 19;59(RR-2):1-9. Erratum in: MMWR Recomm Rep. 2010 Apr 30;59(16):493.

PMID:
20300058
[PubMed - indexed for MEDLINE]
Free Article
3.

Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.

Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, Sun B, Hull HF; Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 May 23;57(RR-3):1-28.

PMID:
18496505
[PubMed - indexed for MEDLINE]
Free Article
4.

[Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].

Koprowski H.

Arch Immunol Ther Exp (Warsz). 2002;50(6):365-9. Polish.

PMID:
12549429
[PubMed - indexed for MEDLINE]
5.

Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.

Müller T, Dietzschold B, Ertl H, Fooks AR, Freuling C, Fehlner-Gardiner C, Kliemt J, Meslin FX, Franka R, Rupprecht CE, Tordo N, Wanderler AI, Kieny MP.

PLoS Negl Trop Dis. 2009 Nov 3;3(11):e542. doi: 10.1371/journal.pntd.0000542. Erratum in: PLoS Negl Trop Dis. 2009;3(11): doi: 10.1371/annotation/df98339d-6bdb-40ed-af83-cc38b249264a. Franka, Richard [added].

PMID:
19888334
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Postexposure prophylaxis for rabies in resource-limited/poor countries.

Shantavasinkul P, Wilde H.

Adv Virus Res. 2011;79:291-307. doi: 10.1016/B978-0-12-387040-7.00013-5. Review.

PMID:
21601051
[PubMed - indexed for MEDLINE]
7.

The incurable wound revisited: progress in human rabies prevention?

Hanlon CA, Niezgoda M, Morrill PA, Rupprecht CE.

Vaccine. 2001 Mar 21;19(17-19):2273-9.

PMID:
11257347
[PubMed - indexed for MEDLINE]
8.

Human rabies encephalitis prevention and treatment: progress since Pasteur's discovery.

Dacheux L, Delmas O, Bourhy H.

Infect Disord Drug Targets. 2011 Jun;11(3):251-99. Review.

PMID:
21488832
[PubMed - indexed for MEDLINE]
9.

Reinvestigating the role of IgM in rabies virus postexposure vaccination.

Dorfmeier CL, Shen S, Tzvetkov EP, McGettigan JP.

J Virol. 2013 Aug;87(16):9217-22. doi: 10.1128/JVI.00995-13. Epub 2013 Jun 12.

PMID:
23760250
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.

Sun L, Chen Z, Yu L, Wei J, Li C, Jin J, Shen X, Lv X, Tang Q, Li D, Liang M.

Appl Microbiol Biotechnol. 2012 Oct;96(2):357-66. doi: 10.1007/s00253-012-4171-4. Epub 2012 Jun 9.

PMID:
22678022
[PubMed - indexed for MEDLINE]
11.

Human monoclonal antibody and vaccine approaches to prevent human rabies.

Nagarajan T, Rupprecht CE, Dessain SK, Rangarajan PN, Thiagarajan D, Srinivasan VA.

Curr Top Microbiol Immunol. 2008;317:67-101. Review.

PMID:
17990790
[PubMed - indexed for MEDLINE]
12.

Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.

Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, Kruif Jd, Dietzschold B, Bakker AB, Rupprecht CE.

J Infect Dis. 2006 Mar 15;193(6):796-801. Epub 2006 Feb 6.

PMID:
16479514
[PubMed - indexed for MEDLINE]
Free Article
13.

New approaches to the prevention and eradication of rabies.

Dietzschold B, Faber M, Schnell MJ.

Expert Rev Vaccines. 2003 Jun;2(3):399-406. Review.

PMID:
12903805
[PubMed - indexed for MEDLINE]
14.

Rabies research in resource-poor countries.

Wilde H, Lumlertdacha B.

Adv Virus Res. 2011;79:449-55. doi: 10.1016/B978-0-12-387040-7.00021-4. Review.

PMID:
21601059
[PubMed - indexed for MEDLINE]
15.

Treatment of rabies in the 21st century: curing the incurable?

Franka R, Rupprecht CE.

Future Microbiol. 2011 Oct;6(10):1135-40. doi: 10.2217/fmb.11.92.

PMID:
22004032
[PubMed - indexed for MEDLINE]
16.

Immunogenicity and efficacy of Fermi-type nerve tissue rabies vaccine in mice and in humans undergoing post-exposure prophylaxis for rabies in Ethiopia.

Ayele W, Fekadu M, Zewdie B, Beyene M, Bogale Y, Mocha K, Egziabher FG.

Ethiop Med J. 2001 Oct;39(4):313-21.

PMID:
12380231
[PubMed - indexed for MEDLINE]
17.

The challenge to provide affordable rabies post-exposure treatment.

Warrell MJ.

Vaccine. 2003 Jan 30;21(7-8):706-9.

PMID:
12531345
[PubMed - indexed for MEDLINE]
18.

Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals.

Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett S, Levis R, Meltzer MI, Schaffner W, Cieslak PR.

Vaccine. 2009 Nov 27;27(51):7141-8. doi: 10.1016/j.vaccine.2009.09.029. Review.

PMID:
19925944
[PubMed - indexed for MEDLINE]
19.

Small interfering RNAs targeting the rabies virus nucleoprotein gene.

Yang YJ, Zhao PS, Zhang T, Wang HL, Liang HR, Zhao LL, Wu HX, Wang TC, Yang ST, Xia XZ.

Virus Res. 2012 Oct;169(1):169-74. doi: 10.1016/j.virusres.2012.07.024. Epub 2012 Aug 3.

PMID:
22884777
[PubMed - indexed for MEDLINE]
20.

Therapy of human rabies.

Jackson AC.

Adv Virus Res. 2011;79:365-75. doi: 10.1016/B978-0-12-387040-7.00017-2. Review.

PMID:
21601055
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk